FOXO TECHNOLOGIES INC.

FOXO Technologies Inc., trading under the ticker FOXO, is an insurtech company focused on applying epigenetic biomarker science to the life insurance underwriting process. The company went public through a SPAC merger with CF Acquisition Corp. VIII, a blank-check vehicle sponsored by Cantor Fitzgerald, which completed its IPO in 2021. The November 2021 10-Q filing, submitted under accession number 0001213900-21-059352, reflects the company's financial disclosures during the pre-merger period. FOXO operates at the intersection of health technology and insurance, targeting the longevity analytics sector. Investors tracking FOXO's full filing history, merger timeline, and sponsor details can sign up for complete data on SpacDesk.